Dual In Vitro Perfusion of an Isolated Cotyledon as a Model to Study the Implication of Changes in the Third Trimester Placenta on Preeclampsia

Placenta

Volumn 28, Issue SUPPL., 2007, Pages

  Di Santo, S ^a   Sager, R ^a   Andres, A C ^b   Guller, S ^c   Schneider, H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Microparticles; Oxidative stress; Placental perfusion; Preeclampsia

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE; XANTHINE OXIDASE;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA PERFUSION; PLACENTA VILLUS; PREECLAMPSIA; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; STROMA CELL; THIRD TRIMESTER PREGNANCY; TISSUE HOMOGENATE; TROPHOBLAST; WESTERN BLOTTING;

EID: 33947724728     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.01.009     Document Type: Article

References (48)

1. Hung T., Skepper J., and Burton G. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 159 (2001) 1031-1043
2. Hung T., Skepper J., Charnock-Jones D., and Burton G. Hypoxia/reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90 (2002) 1274-1281
3. Di Santo S., Malek A., Sager R., Andres A., and Schneider H. Trophoblast viability in perfused term placental tissue and explant cultures limited to 7-24 h. Placenta 24 (2003) 882-894
4. Cannell G., Kluck R., Hamilton S., Mortimer R., Hooper W., and Dickinson R. Markers of physical integrity and metabolic viability of the perfused human placental lobule. Clin Exp Pharmacol Physiol 15 (1988) 837-844
5. Miller R., Wier P., Shah Y., Sant'Agnese P.D., and D'Gregorio R. Criteria for in vitro dual perfusions in the human placental lobule: perfusions in excess of 12 h. In: Genbacev O., Klopper A., and Beaconsfiled R. (Eds). Placenta as a model and a source (1989), Plenum Press, New York 27-38
6. Guller S., Ma Y., Malek A., Di Santo S., Schneider H. Differential release of plasminogen activators during dual perfusion of human placenta: implications in preeclampsia. Placenta 2006 Jul 3 [Epub ahead of print].
7. Schneider H., Panigel M., and Dancis J. Transfer across the perfused human placenta of antipyrine, sodium, and leucine. Am J Obstet Gynecol 114 (1972) 822-828
8. vanWijk M., Nieuwland R., Boer K., van der Post J., VanBavel E., and Sturk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?. Am J Obstet Gynecol 187 (2002) 450-456
9. Redman C., and Sargent I. Placental debris, oxidative stress and preeclampsia. Placenta 21 (2000) 597-602
10. Sargent I., Germain S., Sacks G., Kumar S., and Redman C. Trophoblast deportation and the maternal inflammatory response in preeclampsia. J Reprod Immunol 59 (2003) 153-160
11. Hubel C. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
12. Schneider H. Placental oxygen consumption. Part II: in vitro studies-a review. Placenta 21 Suppl. A (2000) S38-S44
13. Challier J., Schneider H., and Dancis J. In vitro perfusion of human placenta V. Oxygen consumption. Am J Obstet Gynecol 6 (1976) 261-265
14. Myatt L., and Cui X. Oxidative stress in the placenta. Histochem Cell Biol 122 (2004) 369-382
15. Poston L., and Raijmakers M. Trophoblast oxidative stress, antioxidants and pregnancy outcome-a review. Placenta 25 Suppl. A (2004) S72-S78
16. Chappell L., Seed P., Briley A., Kelly F., Hunt B., Charnock-Jones D., et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 187 (2002) 127-136
17. Raijmakers M., Peters W., Steegers E., and Poston L. NAD(P)H oxidase associated superoxide production in human placenta from normotensive and pre-eclamptic women. Placenta 25 Suppl. A (2004) S85-S89
18. Cui X., Brockman D., Campos B., and Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27 (2006) 422-431
19. Myatt L., Rosenfied R.B., Eis A.L., Brockman D.E., Greer I., and Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28 (1996) 488-493
20. Many A., Hubel C., Fisher S., Roberts J., and Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 156 (2000) 321-331
21. Cester N., Staffolani R., Rabini R., Magnanelli R., Salvolini E., Galassi R., et al. Pregnancy induced hypertension: a role for peroxidation in microvillus plasma membranes. Mol Cell Biochem 131 (1994) 51-55
22. Walsh S., Vaughan J., Wang Y., and Roberts L.N. Placental isoprostane is significantly increased in preeclampsia. FASEB J (2000) 1289-1296
23. Kim Y., Kim C., Cho M., Kim K., Lee S., Ahn B., et al. Total peroxyl radical-trapping ability and anti-oxidant vitamins in umbilical veinous plasma and the placental in preeclampsia. J Obstet Gynaecol Res 32 (2006) 32-41
24. Kay H., Tsoi S., Grindle K., and Magness R. Markers of oxidative stress in placental villi exposed to ethanol. J Soc Gynecol Investig 13 (2006) 118-121
25. Estelles A., Gilabert J., Aznar J., Loskutoff D., and Schleef R. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 74 (1989) 1332-1338
26. Estelles A., Gilabert J., Keeton M., Eguchi Y., Aznar J., Grancha S., et al. Altered expression of plasmonogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine growth retardation. Blood 84 (1994) 143-150
27. Jauniaux E., Watson A., Bao Y., Hempstock J., Skepper J., and Burton G. Onset of maternal arterial blood flow and placental oxidative stress. Am J Pathol 157 (2000) 2111-2122
28. Hempstock J., Bao Y., Bar-Isaac M., Segaren N., Watson A., Charnock-Jones D., et al. Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial blood flow within the human placenta. Placenta 24 (2003) 517-523
29. Wang Y., and Walsh S. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta 22 (2001) 206-212
30. Malek A., Sager R., and Schneider H. Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta 22 Suppl. A (2001) S45-S50
31. Redman C., and Sargent I. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 24 (2003) S21-S27
32. Knight M., Redman C., Linton E., and Sargent I. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 105 (1998) 632-640
33. VanWijk M.J., VanBavel E., Sturk A., and Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 59 (2003) 277-287
34. Smarason A., Sargent I., Starkey P., and Redman C. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 100 (1993) 943-949
35. Cockell A., Learmont J., Smarason A., Redman C., Sargent I., and Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 104 (1997) 235-240
36. vanWijk M., Svedas E., Boer K., Nieuwland R., Vanbavel E., and Kublickiene K. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 187 (2002) 1686-1693
37. Sacks G., Studena K., Sargent I., and Redman C. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179 (1998) 80-86
38. Redman C., Sacks G., and Sargent I. Preeclampsia an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180 (1999) 499-506
39. von Dadelszen P., Magee L., Marshall J., and Rotstein O. The maternal syndrome of preeclampsia: a forme fruste of the systemic inflammatory response syndrome. Sepsis 4 (2000) 43-47
40. Aly A., Khandelwal M., Zhao J., Mehmet A., Sammel M., and Parry S. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am J Obstet Gynecol 190 (2004) 252-258
41. Goswami D., Tannetta D., Magee L., Fuchisawa A., Redman C., Sargent I., et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset preeclampsia, but not normotensive intrauterine growth restriction. Placenta (2006) 56-61
42. Huppertz B., Kingdom J., Caniggia I., Desoye G., Black S., Knorr H., et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 24 (2003) 181-190
43. Huppertz B., and Kingdom J. Apoptosis in the trophoblast - role of apoptosis in placental morphogenesis. J Soc Gynecol Invest 11 (2004) 353-362
44. Gupta A., Holzgreve W., Huppertz B., Malek A., Schneider H., and Hahn S. Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin Chem 50 (2004) 2187-2190
45. Gupta A., Rusterholz C., Huppertz B., Malek A., Schneider H., Holzgreve W., et al. A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta 26 (2005) 59-66
46. Mellembakken J., Aukrust P., Hestdal K., Ueland T., Abyholm T., and Videm V. Chemokines and leucocyte activation in the fetal circulation during preeclampsia. Hypertension 38 (2001) 394-398
47. Davidge S., Signorella A., Lykins D., Gilmour C., and Roberts J. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol 175 (1996) 1301-1306
48. Soleymanlou N., Jurisica I., Nevo O., Ietta F., Zhang X., Zamudio S., et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 90 (2005) 4299-4308